A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments.

Correctly distinguishing between look-alike tumors found in the brain during surgery can guide critical decisions in real ...

Laertis Ikonomou, PhD, associate professor of oral biology, is the principal investigator of a two-year, $435,167 R21 grant ...

The model posted an Instagram photo of herself recuperating from her treatment, while mom Yolanda added a touching message of ...

Violent incidents are increasing at health care settings, including hospitals. Medical professionals worry about their safety ...

METiS TechBio, a pioneer in AI-powered nano-delivery innovation, announced the official launch of NanoForge, the ...

There was a time, in the early 2000s, when I loved football with such naive intensity that I wore a different NFL jersey to ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...

It is now well accepted that cells of the nervous and immune systems communicate through bidirectional signaling mediated by the release of cytokines, ...

Agentic AI is already changing how security operations centers function, handling repeatable tasks and freeing analysts for ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...